Pulmonology
Latest News
Paxlovid and Lagevrio benefit COVID outpatients in Omicron era
In a update of the rapid practice point guideline for outpatient treatment of COVID-19, the American College of Physicians found that nirmatrelvir...
Conference Coverage
Diagnosing progressive pulmonary fibrosis
Despite advancements in PPF diagnosis, considerable challenges persist in diagnosing this recently defined phenotype.
From the Journals
Minimally invasive surfactant shows some benefit in infants’ first 2 years
MIST, compared with sham treatment, did not reduce death or neurodevelopmental disability, but infants who received MIST had lower rates of poor...
News from the FDA/CDC
FDA panel deems phenylephrine ineffective
The committee’s next move is to determine if the drug’s status as Generally Recognized as Safe and Effective should be revoked.
Latest News
Navigating chronic cough in primary care
“The most common associated comorbidities were heart failure and hypertension, but also conditions related to chronic pain, mood, and anxiety.”
Latest News
Growing public perception that cannabis is safer than tobacco
There was a significant shift over time toward an increasingly favorable perception of cannabis; more respondents reported cannabis was “somewhat...
Latest News
Adaptive treatment aids smoking cessation
Patches for smoking cessation were more successful with added bupropion for nonresponders.
From the Journals
Young vapers and smokers beware: Eye problems abound
Use of both cigarettes and vapes is apparently much worse for eye health than either product use alone, a new study found.
Article
Mepolizumab improves asthma after 1 year despite comorbidities
Patients with asthma and comorbid chronic rhinosinusitis with nasal polyps showed especially significant benefits.
Conference Coverage
Screening finds high rates of CVD in diabetes, COPD patients
The study tested a “very simple” symptom questionnaire as the initial screening phase, yet resulted in a CVD diagnostic rate that was two- to...
Feature
Dupilumab gains off-label uses as clinicians turn to drug for more indications
As the roster of approved and off-label indications grows, skin specialists said, pediatricians and other primary care providers should become...